In this Bloomberg Law article you'll learn about:
- Independent pharmacies say pharmacy benefit managers' integration with retail pharmacies is hurting them.
- The Federal Trade Commission is investigating whether PBMs' practices are anticompetitive. Analysts say the agency should examine concrete data to reach conclusions on what practices are fueling skyrocketing drug costs.
- The total number of independent pharmacies in the US increased by 8% from 2012 to 2022. There are currently more than 23,000 independent pharmacy locations across the US. The study is based on data collected by the National Council for Prescription Drug Programs (NCPDP).